Bhaskar Anand - Net Worth and Insider Trading
Bhaskar Anand Net Worth
The estimated net worth of Bhaskar Anand is at least $4 Million dollars as of 2025-07-03. Bhaskar Anand is the SVP, Chief Accounting Officer of Reata Pharmaceuticals Inc and owns about 24,089 shares of Reata Pharmaceuticals Inc (RETA) stock worth over $4 Million. Details can be seen in Bhaskar Anand's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bhaskar Anand has not made any transactions after 2023-09-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bhaskar Anand
Bhaskar Anand Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bhaskar Anand owns 1 companies in total, including Reata Pharmaceuticals Inc (RETA) .
Click here to see the complete history of Bhaskar Anand’s form 4 insider trades.
Insider Ownership Summary of Bhaskar Anand
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| RETA | Reata Pharmaceuticals Inc | 2023-09-26 | SVP & Chief Accounting Officer |
Bhaskar Anand Latest Holdings Summary
Bhaskar Anand currently owns a total of 1 stock. Bhaskar Anand owns 24,089 shares of Reata Pharmaceuticals Inc (RETA) as of September 5, 2023, with a value of $4 Million.
Latest Holdings of Bhaskar Anand
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RETA | Reata Pharmaceuticals Inc | 2023-09-05 | 24,089 | 172.36 | 4,151,980 |
Holding Weightings of Bhaskar Anand
Bhaskar Anand Form 4 Trading Tracker
According to the SEC Form 4 filings, Bhaskar Anand has made a total of 5 transactions in Reata Pharmaceuticals Inc (RETA) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Reata Pharmaceuticals Inc is the sale of 406 shares on September 5, 2023, which brought Bhaskar Anand around $68,695.
Insider Trading History of Bhaskar Anand
- 1
Bhaskar Anand Trading Performance
Bhaskar Anand Ownership Network
Ownership Network List of Bhaskar Anand
Ownership Network Relation of Bhaskar Anand
Bhaskar Anand Owned Company Details
What does Reata Pharmaceuticals Inc do?
Who are the key executives at Reata Pharmaceuticals Inc?
Bhaskar Anand is the SVP & Chief Accounting Officer of Reata Pharmaceuticals Inc. Other key executives at Reata Pharmaceuticals Inc include director & 10 percent owner Antal Rohit Desai , EVP & Chief R&D Officer Rajiv Patni , and SVP & Global Regulatory Affairs Andrea Loewen .
Reata Pharmaceuticals Inc (RETA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Reata Pharmaceuticals Inc (RETA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Reata Pharmaceuticals Inc (RETA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Reata Pharmaceuticals Inc (RETA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Reata Pharmaceuticals Inc Insider Transactions
Bhaskar Anand Mailing Address
Above is the net worth, insider trading, and ownership report for Bhaskar Anand. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Bhaskar Anand's mailing address is: Plano Tx 75024.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
